Kuruma Hidetoshi, Egawa Shin
Dept. of Urology, Kitasato University School of Medicine, 1-15-1 Kitasato, Sagamihara, Kanagawa 228-8555, Japan.
Gan To Kagaku Ryoho. 2003 Jan;30(1):11-5.
Prostate-specific antigen (PSA) is the most useful tumor marker available today. However, its inability to clearly distinguish between prostate cancer and benign prostatic hyperplasia may result in serial and unnecessary prostate biopsies. Various attempts have been made to improve its specificity. PSA-related parameters including PSA density, PSA density for the transition zone, age- or race-specific PSA reference range, PSA velocity, and percent free PSA are the most promising approaches available at present.
前列腺特异性抗原(PSA)是目前可用的最有用的肿瘤标志物。然而,它无法清楚地区分前列腺癌和良性前列腺增生,可能导致一系列不必要的前列腺活检。人们已经进行了各种尝试来提高其特异性。与PSA相关的参数,包括PSA密度、移行区PSA密度、年龄或种族特异性PSA参考范围、PSA速率和游离PSA百分比,是目前最有前景的方法。